Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
| Actual shortage: | 247 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-01-26 | 2023-02-23 | 182382 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Actual shortage | 2023-01-30 | 2023-07-31 | 182684 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-02-02 | 2023-04-27 | 183474 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-02-02 | 2023-06-23 | 183477 |
| APO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-02-02 | 2023-03-16 | 183480 |
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-02-02 | 2023-04-14 | 183483 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 10MG | TABLET | Resolved | 2023-02-02 | 2023-03-02 | 183486 |
| APO-HYDROXYUREA | 500MG | CAPSULE CAPSULE | Resolved | 2023-02-02 | 2023-02-09 | 183489 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-02-02 | 2023-02-23 | 183492 |
| APO-CEFUROXIME | 250MG | TABLET | Resolved | 2023-02-02 | 2023-02-09 | 183495 |
| APO-TRIMEBUTINE | 100MG | TABLET | Resolved | 2023-02-03 | 2023-04-17 | 183589 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-05-12 | 184072 |
| APO-DOXAZOSIN | 1MG | TABLET | Resolved | 2023-02-09 | 2023-03-23 | 184077 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-02-09 | 2023-02-16 | 184080 |
| APO-OLANZAPINE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-06-02 | 184083 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-09 | 2023-03-02 | 184086 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-02-09 | 2023-03-16 | 184089 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2023-02-09 | 2023-09-22 | 184092 |
| APO-OLANZAPINE | 20MG | TABLET | Resolved | 2023-02-09 | 2023-06-02 | 184097 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-09 | 2023-02-23 | 184100 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
| APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
| APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |